By Shrividya Iyer, PhD, Oncology Lead, US HEOR & RWE, and Sanjay Gupta, PhD, MBA, Department Head, Health Economics, Outcomes Research and Real World Evidence Over the past decade, the term...

By Caroline Ojaimi, Director, US Medical Affairs, Strategy and Operations In late 2019, before the coronavirus pandemic, our Medical Affairs team at Eisai realigned our priorities. We agreed that...

By Luca Dezzani, Vice President, U.S. Medical Affairs, Oncology Business Group In the wake of COVID-19, we were forced into a virtual world that, in many ways, we weren’t entirely ready for. We...

By Asya Kogan, Executive Director, Field Medical, Oncology, Eisai For a medical science liaison (MSL), being “in the field” isn’t what it used to be. Over the years, quite a lot has...

By Tracey Cannova, Associate Medical Director, US Oncology Medical AffairsBy Tracey Cannova, Associate Medical Director, US Oncology Medical Affairs Working in medical affairs is exciting and...